HRP20181453T1 - Protutijelo koje može specifično prepoznavati receptor transferina - Google Patents
Protutijelo koje može specifično prepoznavati receptor transferinaInfo
- Publication number
- HRP20181453T1 HRP20181453T1 HRP20181453TT HRP20181453T HRP20181453T1 HR P20181453 T1 HRP20181453 T1 HR P20181453T1 HR P20181453T T HRP20181453T T HR P20181453TT HR P20181453 T HRP20181453 T HR P20181453T HR P20181453 T1 HRP20181453 T1 HR P20181453T1
- Authority
- HR
- Croatia
- Prior art keywords
- transferrin receptor
- antibody capable
- specifically recognizing
- recognizing transferrin
- specifically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012246215 | 2012-11-08 | ||
| EP13853637.0A EP2918603B1 (en) | 2012-11-08 | 2013-11-08 | Antibody capable of specifically recognizing transferrin receptor |
| PCT/JP2013/080249 WO2014073641A1 (ja) | 2012-11-08 | 2013-11-08 | トランスフェリン受容体を特異的に認識できる抗体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20181453T1 true HRP20181453T1 (hr) | 2018-12-14 |
Family
ID=50684735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20181453TT HRP20181453T1 (hr) | 2012-11-08 | 2018-09-11 | Protutijelo koje može specifično prepoznavati receptor transferina |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9593165B2 (hr) |
| EP (1) | EP2918603B1 (hr) |
| JP (1) | JP6212497B2 (hr) |
| CN (1) | CN104797600A (hr) |
| AU (1) | AU2013342432A1 (hr) |
| CA (1) | CA2893794C (hr) |
| CY (1) | CY1121158T1 (hr) |
| DK (1) | DK2918603T3 (hr) |
| ES (1) | ES2689782T3 (hr) |
| HK (1) | HK1213582A1 (hr) |
| HR (1) | HRP20181453T1 (hr) |
| HU (1) | HUE039920T2 (hr) |
| LT (1) | LT2918603T (hr) |
| PL (1) | PL2918603T3 (hr) |
| PT (1) | PT2918603T (hr) |
| RS (1) | RS57696B1 (hr) |
| SI (1) | SI2918603T1 (hr) |
| WO (1) | WO2014073641A1 (hr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017023862A2 (pt) | 2015-05-04 | 2018-07-17 | Cytomx Therapeutics Inc | anticorpos anti-cd71, anticorpos anti-cd71 ativáveis, e métodos de uso destes |
| LT3325509T (lt) * | 2015-07-22 | 2021-06-10 | Inatherys | Anti-tfr antikūnai ir jų panaudojimas proliferacinių ir uždegiminių sutrikimų gydymui |
| AU2019384781A1 (en) * | 2018-11-20 | 2021-06-10 | Perseus Proteomics Inc. | Agent for inhibiting iron uptake into cells |
| CN114364699B (zh) * | 2019-09-04 | 2024-03-29 | 株式会社英仙蛋白质科学 | 红细胞增多症治疗药 |
| EP4031696A4 (en) * | 2019-09-20 | 2023-02-22 | Navi Bio-Therapeutics, Inc. | PERSONALIZED CANCER IMMUNOTHERAPY |
| EP4066858A4 (en) * | 2019-11-27 | 2023-12-27 | Perseus Proteomics Inc. | THERAPEUTIC AGENT FOR CARCINOMATOUS PERITONITIS |
| US20240288453A1 (en) | 2020-10-08 | 2024-08-29 | National University Corporation Tokai National Higher Education And Research System | Method for determining medicinal effect or sensitivity of anti-transferrin receptor antibody |
| EP4393509A1 (en) | 2021-08-26 | 2024-07-03 | Perseus Proteomics Inc. | Reactive oxygen species (ros) production promoter |
| MX2024002753A (es) | 2021-09-01 | 2024-05-20 | Biogen Ma Inc | Anticuerpos anti receptor de transferrina y usos de los mismos. |
| WO2023204181A1 (ja) * | 2022-04-19 | 2023-10-26 | 学校法人東海大学 | Ｎｋ細胞腫瘍の治療剤 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5589211A (en) | 1985-06-24 | 1996-12-31 | Cox; James P. | Methods for processing poultry shell eggs |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| CA2081368A1 (en) | 1990-03-27 | 1991-09-28 | Ian S. Trowbridge | Method for inhibiting cell growth and compositions useful therefor |
| AU665190B2 (en) | 1990-07-10 | 1995-12-21 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5165424A (en) | 1990-08-09 | 1992-11-24 | Silverman Harvey N | Method and system for whitening teeth |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| WO1993006213A1 (en) | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| JPH07503132A (ja) | 1991-12-17 | 1995-04-06 | ジェンファーム インターナショナル，インコーポレイティド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| US5777085A (en) | 1991-12-20 | 1998-07-07 | Protein Design Labs, Inc. | Humanized antibodies reactive with GPIIB/IIIA |
| DE69331089T2 (de) | 1992-02-18 | 2002-07-18 | Otsuka Kagaku K.K., Osaka | Beta-Laktam und Cepham Verbindungen und Ihre Herstellung |
| US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| EP0656941B1 (en) | 1992-03-24 | 2005-06-01 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| JPH08509612A (ja) | 1993-04-26 | 1996-10-15 | ジェンファーム インターナショナル インコーポレイテッド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| GB9313509D0 (en) | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
| AU690171B2 (en) | 1993-12-03 | 1998-04-23 | Medical Research Council | Recombinant binding proteins and peptides |
| DE69637481T2 (de) | 1995-04-27 | 2009-04-09 | Amgen Fremont Inc. | Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8 |
| AU2466895A (en) | 1995-04-28 | 1996-11-18 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| AU690474B2 (en) | 1995-09-11 | 1998-04-23 | Kyowa Hakko Kirin Co., Ltd. | Antibody againts alpha-chain of human interleukin 5 receptor |
| JP4870348B2 (ja) * | 2003-12-04 | 2012-02-08 | 株式会社ペルセウスプロテオミクス | 細胞表面抗原に対する抗体取得とその抗原同定 |
| WO2005111082A1 (en) | 2004-04-30 | 2005-11-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Anti-tfr antibody. |
| CA2580141C (en) | 2004-09-23 | 2013-12-10 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| JP4942644B2 (ja) | 2005-02-28 | 2012-05-30 | 株式会社抗体研究所 | 抗ＩｇＳＦ４抗体及びその利用 |
| EP2975057A1 (en) | 2006-07-10 | 2016-01-20 | Fujita Health University | Novel anti-cd73 antibody |
| CN101245107B (zh) * | 2007-02-14 | 2010-10-13 | 中国人民解放军军事医学科学院生物工程研究所 | 抗人转铁蛋白受体人源抗体及其应用 |
| US7973019B1 (en) | 2007-10-03 | 2011-07-05 | Alcon Research, Ltd. | Transferrin/transferrin receptor-mediated siRNA delivery |
| FR2953841B1 (fr) | 2009-12-16 | 2011-12-30 | Centre Nat Rech Scient | Anticorps diriges contre le recepteur de la transferrine et leurs utilisations pour l'immunotherapie des tumeurs qui dependent du fer |
| US9598496B2 (en) | 2011-05-09 | 2017-03-21 | Perseus Proteomics Inc. | Antibody capable of specifically recognizing transferrin receptor |
| WO2013031619A1 (ja) * | 2011-08-26 | 2013-03-07 | 学校法人藤田学園 | 抗ヒトトランスフェリン受容体抗体を含む画像用腫瘍診断剤 |
| JP5939855B2 (ja) * | 2012-03-23 | 2016-06-22 | 国立大学法人 宮崎大学 | トランスフェリン受容体抗体 |
-
2013
- 2013-11-08 LT LTEP13853637.0T patent/LT2918603T/lt unknown
- 2013-11-08 JP JP2014545766A patent/JP6212497B2/ja active Active
- 2013-11-08 EP EP13853637.0A patent/EP2918603B1/en active Active
- 2013-11-08 RS RS20181120A patent/RS57696B1/sr unknown
- 2013-11-08 CA CA2893794A patent/CA2893794C/en active Active
- 2013-11-08 SI SI201331165T patent/SI2918603T1/sl unknown
- 2013-11-08 US US14/441,307 patent/US9593165B2/en active Active
- 2013-11-08 CN CN201380058622.3A patent/CN104797600A/zh active Pending
- 2013-11-08 PT PT13853637T patent/PT2918603T/pt unknown
- 2013-11-08 DK DK13853637.0T patent/DK2918603T3/en active
- 2013-11-08 AU AU2013342432A patent/AU2013342432A1/en not_active Abandoned
- 2013-11-08 PL PL13853637T patent/PL2918603T3/pl unknown
- 2013-11-08 ES ES13853637.0T patent/ES2689782T3/es active Active
- 2013-11-08 HU HUE13853637A patent/HUE039920T2/hu unknown
- 2013-11-08 WO PCT/JP2013/080249 patent/WO2014073641A1/ja active Application Filing
-
2016
- 2016-02-14 HK HK16101588.8A patent/HK1213582A1/zh unknown
-
2018
- 2018-09-11 HR HRP20181453TT patent/HRP20181453T1/hr unknown
- 2018-10-05 CY CY20181101031T patent/CY1121158T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1121158T1 (el) | 2020-05-29 |
| EP2918603A4 (en) | 2016-06-29 |
| US20150291697A1 (en) | 2015-10-15 |
| ES2689782T3 (es) | 2018-11-15 |
| RS57696B1 (sr) | 2018-12-31 |
| WO2014073641A1 (ja) | 2014-05-15 |
| HK1213582A1 (zh) | 2016-07-08 |
| JPWO2014073641A1 (ja) | 2016-09-08 |
| US9593165B2 (en) | 2017-03-14 |
| SI2918603T1 (sl) | 2018-12-31 |
| HUE039920T2 (hu) | 2019-02-28 |
| PL2918603T3 (pl) | 2019-01-31 |
| DK2918603T3 (en) | 2018-10-15 |
| JP6212497B2 (ja) | 2017-10-11 |
| CA2893794C (en) | 2021-11-09 |
| CN104797600A (zh) | 2015-07-22 |
| CA2893794A1 (en) | 2014-05-15 |
| EP2918603A1 (en) | 2015-09-16 |
| LT2918603T (lt) | 2018-10-25 |
| EP2918603B1 (en) | 2018-08-29 |
| PT2918603T (pt) | 2018-10-30 |
| AU2013342432A1 (en) | 2015-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181453T1 (hr) | Protutijelo koje može specifično prepoznavati receptor transferina | |
| HK1201296A1 (en) | Modified fc region of antibody fc | |
| HK1193833A1 (zh) | 能夠特異性識別轉鐵蛋白受體的抗體 | |
| ZA201502213B (en) | Antibodies recognizing alpha-synuclein | |
| HK1204571A1 (en) | Protease-regulated antibodies | |
| HK1210192A1 (en) | Anti-siglec-15 antibodies siglec-15 | |
| AP2014008102A0 (en) | Anti-FcRn antibodies | |
| EP2930240A4 (en) | ANTI-FOLR1 ANTIBODY | |
| EP2832855A4 (en) | NEW ANTI-SIGLEC ANTIBODY-15 | |
| EP2844290A4 (en) | NOVEL ANTIBODIES | |
| ZA201407316B (en) | Anti-fgfr2 antibody | |
| EP2861623A4 (en) | NEW SPECIFIC CLEC14A ANTIBODY AND USES THEREOF | |
| EP2826790A4 (en) | GREMLIN-1 ANTIBODY | |
| ZA201407079B (en) | Cdr-modified anti-siglec-15 antibody | |
| HK1210186A1 (en) | Anti-h7cr antibodies h7cr | |
| GB201220242D0 (en) | Antibody | |
| HK1202454A1 (en) | Anti-p-selectin antibody formulation -p- | |
| HK1199040A1 (en) | Use of antibody | |
| EP2804876A4 (en) | NEW ANTIBODIES | |
| EP2848633A4 (en) | ANTI-CXADR ANTIBODY | |
| HK1210182A1 (en) | Anti-prokineticin receptor (prokr) antibodies and uses thereof (prokr) | |
| HK1201845A1 (en) | Monoclonal antibody capable of specifically recognizing asparagine synthase | |
| EP2811018A4 (en) | ANTI-BODY ANTI-sAPPß | |
| GB201209584D0 (en) | Modified antibodies |